Steven R. Ph.D. Gullans
CIK 1571997 · President & CEO · last filed 2024-05-20
Steven R. Ph.D. Gullans is a President & CEO who has filed 14 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for ISPC, was dated May 20, 2024. Across all open-market trades the lifetime net is +$9.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $8 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8
4
14
$9.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ISPC | Director | 4 | $1.97 | $8 | $0 | 3 | 2024-05-20 |
| MetaVia Inc. (NRBO) Delisted | Director | — | $2.36 | — | $0 | 1 | 2020-01-15 |
| MetaVia Inc. (GEMP) Delisted | President & CEO | 49,210 | — | — | $6.00M | 9 | 2019-07-26 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | 48,619 | — | — | $3.47M | 1 | 2013-03-27 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-20 | ISPC | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | ISPC | Grant (A) | +125 | $0 | EDGAR |
| 2023-01-13 | ISPC | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | MetaVia Inc. (NRBO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-26 | MetaVia Inc. (GEMP) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2018-05-24 | MetaVia Inc. (GEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-03 | MetaVia Inc. (GEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-12 | MetaVia Inc. (GEMP) Delisted | Buy (P) | +71,429 | $500.0K | EDGAR |
| 2018-01-30 | MetaVia Inc. (GEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-31 | MetaVia Inc. (GEMP) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.